Monday, December 27, 2010
Momenta Pharmaceuticals Inc., of Cambridge, Mass., said underwriters UBS Investment Bank, Cowen & Co. and Canaccord Genuity exercised their overallotment option related to the biotech's recent public stock offering, purchasing an additional 218,647 shares for $14.35 each in addition to the 4 million shares already sold.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.